Easton Pharmaceuticals (Easton Pharmaceuticals) Total Assets : $9.97 Mil (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Total Assets?

Easton Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2021 was $9.97 Mil.

Total Assets is connected with ROA %. Easton Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2021 was -3.38%. Total Assets is also linked to Revenue through Asset Turnover. Easton Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2021 was 0.00.

Easton Pharmaceuticals Total Assets Historical Data

The historical data trend for Easton Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Total Assets Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Total Assets

Get a 7-Day Free Trial

1.28

1.30

10.15

17.17

10.19

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Total Assets	Get a 7-Day Free Trial															17.17	10.19	9.83	9.90	9.97

Easton Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Easton Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2020 is calculated as

Total Assets	=	Total Equity (A: Dec. 2020 )	+	Total Liabilities (A: Dec. 2020 )
	=	6.909	+	3.283
	=	10.19

Easton Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2021 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2021 )	+	Total Liabilities (Q: Sep. 2021 )
	=	6.647	+	3.32
	=	9.97

Easton Pharmaceuticals (OTCPK:EAPH) Total Assets Explanation

Total Assets is connected with ROA %.

Easton Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2021 is

ROA %	=	Net Income (Q: Sep. 2021 )	/	( (Total Assets (Q: Jun. 2021 )	+	Total Assets (Q: Sep. 2021 ))	/ count )
	=	-0.336	/	( (9.898	+	9.968)	/ 2 )
	=	-0.336	/	9.933
	=	-3.38 %

Note: The Net Income data used here is four times the quarterly (Sep. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Easton Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2021 is

	Asset Turnover
=	Revenue (Q: Sep. 2021 )	/	( (Total Assets (Q: Jun. 2021 )	+	Total Assets (Q: Sep. 2021 ))	/ count )
=	0	/	( (9.898	+	9.968)	/ 2 )
=	0	/	9.933
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Easton Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.